| abstract |
Disclosed are compounds having structural formula (I), or pharmaceutically acceptable salts, amides, esters, or prodrugs thereof. Diseases caused by cancer, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, bone diseases, polyglutamine repeat diseases, anemia, thalassemia, inflammatory conditions, cardiovascular conditions, and angiogenesis Methods and compositions for treating conditions including, but not limited to, compounds of the present invention are disclosed. Also disclosed are methods for modulating histone deacetylase (HDAC) activity. |